Standout Papers

The Pathophysiology of Tumor Necrosis Factors 1989 2026 2001 2013 1.6k
  1. The Pathophysiology of Tumor Necrosis Factors (1992)
    P Vassalli Annual Review of Immunology
  2. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection (1989)
    Vincent Kindler, André‐Pascal Sappino et al. Cell
  3. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. (1990)
    Martine A. Collart, Patrick A. Baeuerle et al. Molecular and Cellular Biology
  4. Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages. (1990)
    Alexander N. Shakhov, Martine A. Collart et al. The Journal of Experimental Medicine
  5. Tumor Necrosis Factor and Disease Severity in Children with Falciparum Malaria (1989)
    Georges E. Grau, Terrie E. Taylor et al. New England Journal of Medicine
  6. Tumor Necrosis Factor (Cachectin) as an Essential Mediator in Murine Cerebral Malaria (1987)
    Georges E. Grau, Luis F. Fajardo et al. Science
  7. In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices. (1983)
    Roberto Montesano, Lelio Orci et al. The Journal of Cell Biology
  8. Two gut intraepithelial CD8+ lymphocyte populations with different T cell receptors: a role for the gut epithelium in T cell differentiation. (1991)
    Delphine Guy‐Grand, Nadine Cerf–Bensussan et al. The Journal of Experimental Medicine
  9. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. (1989)
    P F Piguet, Martine A. Collart et al. The Journal of Experimental Medicine
  10. Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis (1990)
    Pierre F. Piguet, Martine A. Collart et al. Nature
  11. Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease. (1987)
    P F Piguet, Georges E. Grau et al. The Journal of Experimental Medicine
  12. Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors. (1986)
    Martine A. Collart, Dominique Belin et al. The Journal of Experimental Medicine
  13. Comparative studies of intracellular transport of secretory proteins. (1978)
    Alan M. Tartakoff, P Vassalli et al. The Journal of Cell Biology
  14. The mouse gut T lymphocyte, a novel type of T cell. Nature, origin, and traffic in mice in normal and graft-versus-host conditions. (1978)
    Delphine Guy‐Grand, C Griscelli et al. The Journal of Experimental Medicine

Immediate Impact

37 by Nobel laureates 42 from Science/Nature 86 standout
Sub-graph 1 of 19

Citing Papers

Inferences, questions and possibilities in Toll-like receptor signalling
2004 StandoutNatureNobel
Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1
2003 StandoutNature
10 intermediate papers

Works of P Vassalli being referenced

Identical T Cell Clones Are Located within the Mouse Gut Epithelium and Lamina Propria and Circulate in the Thoracic Duct Lymph
2000
Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis.
1995
and 8 more

Author Peers

Author Last Decade Papers Cites
P Vassalli 10186 6097 1357 2757 209 22.2k
Zanvil A. Cohn 13245 10540 2052 2079 233 31.7k
Niels Borregaard 13235 10091 485 1316 253 29.5k
Manfred Köpf 14425 5442 634 1335 230 24.9k
Sharon M. Wahl 14826 7844 1119 1513 272 31.2k
Foo Y. Liew 16943 5296 581 2821 231 28.5k
Samuel D. Wright 13795 9550 1628 1314 217 28.8k
Enrico Maggi 15491 3560 1312 1522 359 26.8k
Bernhard Ryffel 13902 7379 662 1908 434 27.2k
Triantafyllos Chavakis 7780 6026 340 861 261 19.3k
Haruki Okamura 10878 8356 158 1132 238 18.4k

All Works

Loading papers...

Rankless by CCL
2026